Drug Detail:Teriflunomide (Teriflunomide [ ter-i-floo-noe-mide ])
Drug Class: Selective immunosuppressants
Teriflunomide Levels and Effects while Breastfeeding
Summary of Use during Lactation
Because there is no published experience with teriflunomide during breastfeeding, it should be avoided during breastfeeding, especially while nursing a newborn or preterm infant.[1-3]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Multiple Sclerosis) Glatiramer, Immune Globulin, Interferon Beta, Methylprednisolone
References
- 1.
-
Bove R, Alwan S, Friedman JM, et al. Management of multiple sclerosis during pregnancy and the reproductive years: A systematic review. Obstet Gynecol. 2014;124:1157–68. [PubMed: 25415167]
- 2.
-
Almas S, Vance J, Baker T, et al. Management of multiple sclerosis in the breastfeeding mother. Mult Scler Int. 2016;2016:6527458. [PMC free article: PMC4757692] [PubMed: 26966579]
- 3.
-
Dobson R, Dassan P, Roberts M, et al. UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines. Pract Neurol. 2019;19:106–14. [PubMed: 30612100]
Substance Identification
Substance Name
Teriflunomide
CAS Registry Number
163451-81-8
Drug Class
Breast Feeding
Lactation
Immunosuppressive Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification